| ChEMBL: a large-scale bioactivity database for drug discovery A Gaulton, LJ Bellis, AP Bento, J Chambers, M Davies, A Hersey, Y Light, ... Nucleic acids research 40 (D1), D1100-D1107, 2012 | 4446 | 2012 |
| The ChEMBL database in 2017 A Gaulton, A Hersey, M Nowotka, AP Bento, J Chambers, D Mendez, ... Nucleic acids research 45 (D1), D945-D954, 2017 | 2431 | 2017 |
| A comprehensive map of molecular drug targets R Santos, O Ursu, A Gaulton, AP Bento, RS Donadi, CG Bologa, ... Nature reviews Drug discovery 16 (1), 19-34, 2017 | 2362 | 2017 |
| ChEMBL: towards direct deposition of bioassay data D Mendez, A Gaulton, AP Bento, J Chambers, M De Veij, E Félix, ... Nucleic acids research 47 (D1), D930-D940, 2019 | 1931 | 2019 |
| The ChEMBL bioactivity database: an update AP Bento, A Gaulton, A Hersey, LJ Bellis, J Chambers, M Davies, ... Nucleic acids research 42 (D1), D1083-D1090, 2014 | 1684 | 2014 |
| The global phosphorylation landscape of SARS-CoV-2 infection M Bouhaddou, D Memon, B Meyer, KM White, VV Rezelj, MC Marrero, ... Cell 182 (3), 685-712. e19, 2020 | 958 | 2020 |
| ChEMBL web services: streamlining access to drug discovery data and utilities M Davies, M Nowotka, G Papadatos, N Dedman, A Gaulton, F Atkinson, ... Nucleic acids research 43 (W1), W612-W620, 2015 | 681 | 2015 |
| The druggable genome and support for target identification and validation in drug development C Finan, A Gaulton, FA Kruger, RT Lumbers, T Shah, J Engmann, ... Science translational medicine 9 (383), eaag1166, 2017 | 662 | 2017 |
| PRINTS and its automatic supplement, prePRINTS TK Attwood, P Bradley, DR Flower, A Gaulton, N Maudling, AL Mitchell, ... Nucleic acids research 31 (1), 400-402, 2003 | 531 | 2003 |
| Open Targets: a platform for therapeutic target identification and validation G Koscielny, P An, D Carvalho-Silva, JA Cham, L Fumis, R Gasparyan, ... Nucleic acids research 45 (D1), D985-D994, 2017 | 496 | 2017 |
| Unexplored therapeutic opportunities in the human genome TI Oprea, CG Bologa, S Brunak, A Campbell, GN Gan, A Gaulton, ... Nature reviews Drug discovery 17 (5), 317-332, 2018 | 418 | 2018 |
| An open source chemical structure curation pipeline using RDKit AP Bento, A Hersey, E Félix, G Landrum, A Gaulton, F Atkinson, LJ Bellis, ... Journal of Cheminformatics 12, 1-16, 2020 | 385 | 2020 |
| The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods B Zdrazil, E Felix, F Hunter, EJ Manners, J Blackshaw, S Corbett, ... Nucleic acids research 52 (D1), D1180-D1192, 2024 | 336 | 2024 |
| PSICQUIC and PSISCORE: accessing and scoring molecular interactions B Aranda, H Blankenburg, S Kerrien, FSL Brinkman, A Ceol, E Chautard, ... Nature methods 8 (7), 528-529, 2011 | 321 | 2011 |
| The EBI RDF platform: linked open data for the life sciences S Jupp, J Malone, J Bolleman, M Brandizi, M Davies, L Garcia, A Gaulton, ... Bioinformatics 30 (9), 1338-1339, 2014 | 304 | 2014 |
| Pharos: collating protein information to shed light on the druggable genome DT Nguyen, S Mathias, C Bologa, S Brunak, N Fernandez, A Gaulton, ... Nucleic acids research 45 (D1), D995-D1002, 2017 | 278 | 2017 |
| Improving the odds of drug development success through human genomics: modelling study AD Hingorani, V Kuan, C Finan, FA Kruger, A Gaulton, S Chopade, ... Scientific reports 9 (1), 18911, 2019 | 229 | 2019 |
| SureChEMBL: a large-scale, chemically annotated patent document database G Papadatos, M Davies, N Dedman, J Chambers, A Gaulton, J Siddle, ... Nucleic acids research 44 (D1), D1220-D1228, 2016 | 215 | 2016 |
| Activity, assay and target data curation and quality in the ChEMBL database G Papadatos, A Gaulton, A Hersey, JP Overington Journal of computer-aided molecular design 29, 885-896, 2015 | 194 | 2015 |
| Actionable druggable genome-wide Mendelian randomization identifies repurposing opportunities for COVID-19 L Gaziano, C Giambartolomei, AC Pereira, A Gaulton, DC Posner, ... Nature medicine 27 (4), 668-676, 2021 | 193 | 2021 |
